MC1R variants can modify the penetrance of CDKN2A mutations, as carriers of mutations in both genes are at increased risk of developing malignant melanoma compared to individuals carrying a mutation in only one gene [31,39,42–47]. The gene discussed is CDKN2A; the disease is melanoma.